Management of Metastatic Colorectal Carcinoma with GcMAF Forte and Thymus Peptides: A Case Report

Journal of Clinical & Cellular Immunology ◽

10.4172/2155-9899.1000449 ◽

2016 ◽

Vol 7 (4) ◽

Author(s):

Dmitry Klokol ◽

Mikhail Teppone

Keyword(s):

Case Report ◽

Colorectal Carcinoma ◽

Metastatic Colorectal Carcinoma

Download Full-text

Metastatic colorectal carcinoma to one ovary with vanishing primary: A case report in an 18-year- old patient

Clinical Obstetrics Gynecology and Reproductive Medicine ◽

10.15761/cogrm.1000286 ◽

2020 ◽

Vol 6 (2) ◽

Author(s):

Jordy Mehawej ◽

Nicole El Helou ◽

Tanja Pejovic ◽

Paulette Mhawech-Fauceglia

Keyword(s):

Case Report ◽

Colorectal Carcinoma ◽

Metastatic Colorectal Carcinoma

Download Full-text

Metastatic colorectal carcinoma initially diagnosed by bone marrow biopsy: a case report and literature review

Journal of the Egyptian National Cancer Institute ◽

10.1186/s43046-020-00040-6 ◽

2020 ◽

Vol 32 (1) ◽

Author(s):

Reham Alghandour ◽

Gehad A. Saleh ◽

Farida Ahmed Shokeir ◽

Mohammad Zuhdy

Keyword(s):

Bone Marrow ◽

Case Report ◽

Colorectal Carcinoma ◽

Literature Review ◽

Bone Marrow Biopsy ◽

Metastatic Colorectal Carcinoma

Download Full-text

Clinical Responses to Crizotinib, Alectinib, and Lorlatinib in a Metastatic Colorectal Carcinoma Patient With ALK Gene Rearrangement: A Case Report

JCO Precision Oncology ◽

10.1200/po.20.00534 ◽

2021 ◽

pp. 771-778

Author(s):

Xi He ◽

Xiao-Dong Jiao ◽

Ke Liu ◽

Bao-Dong Qin ◽

Ying Wu ◽

...

Keyword(s):

Case Report ◽

Colorectal Carcinoma ◽

Gene Rearrangement ◽

Metastatic Colorectal Carcinoma ◽

Carcinoma Patient ◽

Clinical Responses ◽

Colorectal Carcinoma Patient

Download Full-text

Metastatic colorectal carcinoma mimicking primary ovarian carcinoma presenting as ‘giant’ ovarian tumors in an individual with probable Lynch syndrome: a case report

Journal of Medical Case Reports ◽

10.1186/1752-1947-7-158 ◽

2013 ◽

Vol 7 (1) ◽

Author(s):

Peter A Ongom ◽

Michael Odida ◽

Robert L Lukande ◽

Josephat Jombwe ◽

Emmanuel Elobu

Keyword(s):

Case Report ◽

Colorectal Carcinoma ◽

Lynch Syndrome ◽

Ovarian Carcinoma ◽

Ovarian Tumors ◽

Metastatic Colorectal Carcinoma

Download Full-text

An association between membranoproliferative glomerulonephritis and metastatic colorectal carcinoma: a case report

Journal of Medical Case Reports ◽

10.1186/s13256-016-0979-3 ◽

2016 ◽

Vol 10 (1) ◽

Author(s):

Samuel Chan ◽

Kimberley A. Oliver ◽

Nicholas A. Gray

Keyword(s):

Case Report ◽

Colorectal Carcinoma ◽

Membranoproliferative Glomerulonephritis ◽

Metastatic Colorectal Carcinoma

Download Full-text

Treatment with standardized mistletoe extract (Viscum album L.) Iscador® as a part of long-term supportive care in patients with primary non-metastatic colorectal carcinoma

Zeitschrift für Gastroenterologie ◽

10.1055/s-2007-988193 ◽

2007 ◽

Vol 45 (08) ◽

Author(s):

E Friedel ◽

H Matthes ◽

P Bock

Keyword(s):

Colorectal Carcinoma ◽

Supportive Care ◽

Viscum Album ◽

Metastatic Colorectal Carcinoma ◽

Mistletoe Extract

Download Full-text

Metastatic colorectal carcinoma in a 76-year old male: a pitfall in the diagnosis of unclassified renal cell carcinoma

10.26226/morressier.5b4709866f4cb3001095184e ◽

2018 ◽

Author(s):

Dafne Carvalho Andrade

Keyword(s):

Renal Cell Carcinoma ◽

Colorectal Carcinoma ◽

Cell Carcinoma ◽

Metastatic Colorectal Carcinoma

Download Full-text

Faculty Opinions recommendation of Final analysis of the randomised PEAK trial: overall survival and tumour responses during first-line treatment with mFOLFOX6 plus either panitumumab or bevacizumab in patients with metastatic colorectal carcinoma.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727549021.793550895 ◽

2018 ◽

Author(s):

Sebastian Stintzing

Keyword(s):

Overall Survival ◽

Colorectal Carcinoma ◽

Final Analysis ◽

Line Treatment ◽

Metastatic Colorectal Carcinoma ◽

First Line Treatment

Download Full-text

Influence of BRAF and PIK3CA mutations on the efficacy of FOLFIRI plus bevacizumab or cetuximab as first-line therapy in patients with RAS wild-type metastatic colorectal carcinoma and <3 baseline circulating tumour cells: the randomised phase II VISNÚ-2 study

ESMO Open ◽

10.1016/j.esmoop.2021.100062 ◽

2021 ◽

Vol 6 (2) ◽

pp. 100062

Author(s):

J. Sastre ◽

P. García-Alfonso ◽

J.M. Viéitez ◽

M.T. Cano ◽

F. Rivera ◽

...

Keyword(s):

Colorectal Carcinoma ◽

Phase Ii ◽

Tumour Cells ◽

Circulating Tumour Cells ◽

Wild Type ◽

Metastatic Colorectal Carcinoma ◽

Pik3ca Mutations ◽

First Line Therapy ◽

Download Full-text

Tc-99m DMSA Uptake by Metastatic Colorectal Carcinoma

Clinical Nuclear Medicine ◽

10.1097/01.rlu.0000132948.44939.81 ◽

2004 ◽

Vol 29 (8) ◽

pp. 485-487 ◽

Author(s):

Phivi Rondogianni ◽

George Koniaris

Keyword(s):

Colorectal Carcinoma ◽

Metastatic Colorectal Carcinoma

Download Full-text